Skip to main content
Clinical Trials/CTRI/2019/05/019339
CTRI/2019/05/019339
Completed
Phase 1

Preclinical and clinical evaluation of safety and efficacy of Pramehakulantaka Rasa in the management of Madhumeha w.s.r. to Diabetes Mellitus TypeII

ational Institute of Ayurveda0 sites64 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Enrollment
64
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 14, 2021
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients ready to give concern for the trial \& willing to participate in the study for 3 months.
  • 2\.Patients between the age group of 31\-70 years in either sex.
  • 3\.Newly diagnosed \& confirmed cases of Mahdumeha (Type II Diabetes Mellitus) not talking allopathic drug or Insulin Therapy.
  • 4\.Patients with Fasting Blood Sugar (FBS) in the range of 126mg/dl â?? 250mg/dl or Post Prandial Blood Sugar (PPBS) in the range of 200mg/dl â?? 300 mg/dl and Glycosylated Haemoglobin (HbA1c) 6\.5% \- 9\.0%.
  • 5\.Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P\- polyuria, polydipsia, polyphagia).

Exclusion Criteria

  • 1\.Patients below 31years of age \& above 70 years of age.
  • 2\.Patients having Type I DM.
  • 3\.F.B.S. \> 250 mg/dl and P.P.B.S. \> 300 mg/dl.
  • 4\.Patients of Type II DM who are on insulin therapy and Drug induced DM.
  • 5\.Patients on allopathic anti\-diabetic drug.
  • 6\.DM with complications and Madhumeha with ashadhya upadrava.
  • 7\.Patients having any serious illness like cardiovascular diseases, renal diseases, hepatic diseases, malignancy, any other endocrinopathies etc.
  • 8\.Pregnant and lactating mother.

Outcomes

Primary Outcomes

Not specified

Similar Trials